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A B S T R A C T   
Background: The positive direct relation between stress and the development of cardiovascular disease has 
increasingly been recognized. However, the link between hypothalamic-pituitary-adrenal (HPA) dysregulation 
and subclinical cardiovascular disease has not been studied longitudinally. We investigated the relation of 
diurnal salivary cortisol, as a biological marker of stress levels, with progression of aortic stiffness over five years. 
Methods: A total of 3281 people (mean age 65.5) in the Whitehall II prospective study provided six saliva samples 
on a single weekday. We assessed the diurnal salivary cortisol using the daytime slope and bedtime level. Aortic 
stiffness was measured by carotid-femoral pulse wave velocity (PWV) at baseline (2007–2009) and five years 
later (2012–2013). Linear mixed models were used to estimate the association of diurnal salivary cortisol with 
baseline PWV and five-year longitudinal changes. 
Results: Diurnal salivary cortisol were not associated with PWV at baseline. Among women but not men, a 1-SD 
shallower salivary cortisol slope at baseline was associated with a five-year increase in PWV (β = 0.199; 95% CI 
= 0.040, 0.358 m/s) and higher bedtime cortisol level (β = 0.208, 95% CI = 0.062, 0.354 m/s). 
Conclusions: Dysregulation of the HPA axis measured using salivary cortisol (shallower slope, higher bedtime 
level) predicted the rate of progression of aortic stiffness among women.   
1. Introduction 
The positive direct relation between stress and the development of 
cardiovascular disease has increasingly been recognized in medical 
literature (Kivimaki and Steptoe, 2018). Plausible explanations include 
poor adherence to medical regimens and engaging in unhealthy be-
haviors (e.g. smoking, heavy drinking, being sedentary, poor diet) as 
well as through potentially toxic direct neuroendocrine effects (Rozan-
ski et al., 2005). Evidence for direct stress-related biological alterations 
in pathophysiological pathways is sometimes received with skepticism 
(Black and Garbutt, 2002), however such effects are certainly feasible 
(Brunner, 1997). 
The hypothalamic-pituitary-adrenal (HPA) axis is a major 
component of the neuroendocrine response to chronic psychological 
stress. Repeated activation of HPA axis causes HPA axis dysregulation 
characterized by disturbance of cortisol secretion. Dysregulation of the 
HPA axis may have adverse effects on the cardiovascular system indi-
rectly and directly; indirectly by inducing hypertension, hypercholes-
terolemia, or glucose dysregulation, and directly by modifying 
inflammatory cytokine production and endothelial function (Brunner 
et al., 2002). HPA axis dysregulation may therefore be important in the 
development of arteriosclerosis (Hackett et al., 2016; Black and Garbutt, 
2002). The hypothesis that HPA axis dysregulation is linked to devel-
opment of cardiovascular disease implies that ‘stressed’ HPA func-
tioning predicts progression of arteriosclerosis in the general, healthy 
population (Kirschbaum and Hellhammer, 1989). However, testing this 
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direct stress hypothesis is a challenge and requires a sample of sufficient 
size to measure the circadian patterns of cortisol and the subsequent 
age-related changes in a subclinical measure of arteriosclerosis, such as 
aortic stiffness. 
Three lines of evidence lend support to this hypothesis, First, a 
circadian pattern of cortisol showing a slower and shallower daytime 
cortisol decline has been linked with higher coronary artery calcifica-
tion. Reverse causation may be involved as this evidence is cross- 
sectional (Matthews et al., 2006). Second, both momentary and 
chronic stress have been linked to a similar change in daytime cortisol 
pattern (Liao et al., 2013). Third, a shallower daytime cortisol decline 
predicts incident cardiovascular disease mortality (Kumari et al., 2011) 
and is linked with other adverse health outcomes (Adam et al., 2017). 
We investigated the relation of diurnal salivary cortisol, as a bio-
logical marker of stress levels, with the progression of aortic stiffness 
over five years of follow-up, measured non-invasively by carotid- 
femoral pulse wave velocity (PWV) (Ben-Shlomo et al., 2014; Cifkova 
et al., 2019). We hypothesized that participants with a flatter or shal-
lower decline in cortisol through the day at the baseline of the present 
study would have (i) higher PWV at baseline (2007–2009) and (ii) a 
greater rate of increase in PWV over time (changes from 2007-2009 to 
2012-2013. 
The trajectory of change in cardiovascular risk steeply increases in 
post-menopausal women, potentially at a different rate to the risk in 
men (Brunner et al., 2011). Moreover, chronic stress associated with 
traditional gender roles within settings such as the home (e.g., care 
giving, marital relationship) and workplace (e.g., low autonomy, long 
working hours) can have a profound impact on cardiovascular health 
(O’Neil et al., 2018). There is substantial evidence that cortisol re-
sponses to stress are greater among women than men (Otte et al., 2005). 
Thus, we speculated that the association between diurnal cortisol 
pattern and the progression of aortic stiffness might differ by sex. 
2. Materials and methods 
2.1. Study population 
We used data from the ongoing Whitehall II cohort study. Briefly, 
10,308 male and female London-based civil servants, aged 35–55 years, 
were recruited to the study in 1985, with a response rate of 73% 
Fig. 1. Cohort flowchart.  
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(Marmot et al., 1991). Participants have since been followed up with 
questionnaire surveys and clinical examinations every 4–5 years. Writ-
ten informed consent was obtained from all participants at each 
follow-up clinical examination. The flow diagram indicates the study 
selection process (Fig. 1). Eligibility for the present study required 
continued participation from the time when salivary cortisol was 
collected in 2007–2009 (n = 6225). Of those eligible, 4172 respondents 
provided six completed cortisol measures, completed the logbook and 
sample times, were not taking corticosteroid medications, and took their 
first saliva sample within 15 min of waking based on the protocol for 
cortisol sample collection. As shown in Fig. 1, 111 participants were 
excluded due to lab errors or having an extreme cortisol value (i.e., more 
than three standard deviations (SD) from the mean cortisol concentra-
tion for each of their six samples). Participants who have had a past 
history of myocardial infarction or stroke prior to 2008–2009 were also 
excluded (n = 270). Further participants who did not have a measure-
ment of PWV at either the 2007–2009 or the 2012–2013 clinical ex-
amination were excluded from the final analytic sample. Thus, a total of 
3281 participants (men = 2430, women = 851) who had usable cortisol 
values and at least one measurement of PWV measured during the 
2007–2009 (n = 2766) or the 2012–2013 (n = 2798) clinical exami-
nation were included in the present study. PWV measures were taken 
from 70% of participants at both time points (n = 2283). Participant 
written, informed consent and research ethics approvals are renewed at 
each contact; the latest approval was by the NHS London—Harrow 
Research Ethics Committee, reference number 85/0938. 
2.2. Assessment of PWV 
PWV was assessed between the carotid and femoral sites using 
applanation tonometry (SphygmoCor, AtCor Medical, Sydney, 
Australia). The time difference between the peak of the R-wave on the 
electrocardiogram and the foot of the pulse waveform captured by the 
tonometer at the site of the carotid pulse determined the blood trans-
mission time between the heart and carotid pulse. The blood trans-
mission time between the heart and femoral pulse was measured by the 
same method. The transit time was defined as the difference between the 
heart–carotid and heart–femoral blood transmission times. Path length 
was determined with a tape measure by subtracting the carotid–sternal 
notch distance from the femoral–sternal notch distance. PWV (m/s) was 
calculated by dividing the path length by the transit time (Wilkinson 
et al., 1998). In each participant, PWV was measured twice and if the 
difference in velocity between the two measurements was larger than 
0.5 m/s, a third measurement was taken. The average of the measure-
ments was used in the analysis. 
2.3. Assessment of diurnal salivary cortisol 
The procedure for the collection of salivary cortisol at the 2007–2009 
examination has been reported previously (Abell et al., 2016). Partici-
pants were requested to provide six saliva samples using salivettes over 
the course of a normal weekday at waking (sample 1), waking +30 min 
(sample 2), waking +2.5 h (sample 3), waking +8 h (sample 4), waking 
+12 h (sample 5), and bedtime (sample 6). Participants were asked to 
record the time of sample collection in a logbook and were also required 
to provide information on their wake time. The salivettes and logbook 
were then returned by post. Salivettes were centrifuged at 3000 rpm for 
5 min, resulting in a clear supernatant of low viscosity. Salivary cortisol 
levels were measured using a commercial immunoassay with chem-
iluminescence detection (CLIA; IBL-Hamburg, Hamburg, Germany). The 
limit of detection was 0.44 nmol/l; intra- and inter-assay coefficients of 
variance were less than 8%. The assay identified any hormone levels 
over 50 nmol/l needing to be rerun with diluted samples, to check on the 
validity of the values obtained. 
We used five (waking, +2.5 h, +8 h, +12 h, and bedtime) samples to 
estimate slope in cortisol, with each of the five cortisol values natural 
log-transformed in order to improve the normality of data distribution 
(Supplementary Fig. S1). The skewness for each of these five untrans-
formed cortisol measurements were 1.42, 1.81, 1.60, 3.12, and 3.44, 
respectively. In contrast, the skewness for each of these five log- 
transformed cortisol measurements were − 3.29, − 1.50, − 1.46, − 1.07, 
and − 0.78. Moreover, Q-Q plots of the log-transformed cortisol mea-
surements (Supplementary Fig. S2) suggest adequate normality for the 
distributions of each of these five log-transformed cortisol measure-
ments as well as the slope in cortisol. As these cortisol samples are 
clustered within individuals, the slope in cortisol of individuals were 
estimated using a hierarchical linear model (<Mixed> Stata 14.2; Sta-
taCorp, College Station, TX, USA) in which measurement occasion was 
used as a level 1 identifier and person as a level 2 identifier with sample 
time as the independent variable and random intercepts and random 
slopes (Kumari et al., 2011; Abell et al., 2016). 
2.4. Measurements of other covariates 
Every 4–5 years, participants in the Whitehall II study are followed 
up by clinical examination, a full medical history (myocardial infarction, 
stroke, hypertension, and diabetes mellitus), and measurement of bio-
markers, and complete a questionnaire including lifestyle (smoking, 
alcohol drinking) and psychosocial (employment grade, depression) 
factors. Depression was measured using the Center for Epidemiologic 
Studies Depression Scale (CES-D) (Radloff, 1977). The CES-D consists of 
20 items and the sum of all items for each participant provides the total 
score, which can range between 0 and 60. The British Civil Service 
employment grade was used as a comprehensive measure of socioeco-
nomic status that reflects education, occupational status, and income, 
providing a five-level variable (Marmot et al., 1991). Clinical history of 
myocardial infarction, stroke, hypertension, and diabetes mellitus were 
ascertained by a self-reported doctor diagnosis on questionnaire surveys. 
Medication use was examined by questionnaire and the assessment of 
medications brought by the participant to the clinic visit. Height and 
weight were recorded in light clothing for the calculation of body mass 
index (BMI). After a 5 min rest period, systolic blood pressure (SBP) was 
measured twice using an automated UA-779 digital monitor. Mean 
arterial pressure (MAP) was calculated as diastolic pressure plus 
one-third of the pulse pressure. Serum total cholesterol was determined 
on a Roche P Modular platform after an overnight fast or at least four 
hours after a fat-free breakfast. 
3. Statistical analysis 
Analysis of variance to compare mean values and chi-square tests to 
compare proportions were used in the descriptive analyses of the base-
line characteristics of men and women. Analysis of covariance was used 
to compare age-adjusted mean values of baseline PWV (2007–2009) and 
PWV at 5-year follow-up (2012–2013) between men and women. Linear 
mixed models were used to measure the effect of diurnal salivary cortisol 
(per 1-SD increase) on baseline PWV (2007–2009) and PWV longitudi-
nal changes between 2007-2009 and 2012–2013. These models use all 
available data over the follow-up, handle differences in the length of 
follow-up, and account for correlation between repeated measures on 
the same individual. The linear mixed models included a term for time 
(individual follow-up in years divided by five, to yield effects of change 
over five years). The main effect estimates the effect of diurnal salivary 
cortisol on PWV at baseline (2007–2009), whereas the diurnal salivary 
cortisol × time interaction term estimates the mean difference in the 
five-year change in PWV. A range of covariates, measured closest in time 
to when PWV was measured, were included in all multivariable ana-
lyses. These were age (years), ethnicity (white or non-white), wake-up 
time when cortisol was collected (time), employment grade (low-, 
middle-, or high-grade), CES-D (quartiles), BMI (kg/m2), current smoker 
(yes/no), alcohol intake in the past week (yes/no), total cholesterol 
(mmol/l), SBP (mmHg), MAP (mmHg), hypertension medication use 
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(yes/no), and history of diabetes mellitus (yes/no). Less than 5% of 
participants had missing values in one or more covariates. Missing 
values were replaced by the latest available observation. Although the 
diurnal slope in cortisol secretion for each participant was estimated 
using the STATA statistical package version 14.2 (StataCorp), all other 
analyses were stratified by sex and were conducted using the SAS sta-
tistical package version 9.1 (SAS Institute Inc., Cary, NC, USA). Statis-
tical significance was defined as P < 0.05. 
4. Results 
The 3281 participants in the study sample were younger, contained 
smaller percentages of women and non-whites and generally had a 
better risk profile than the 2944 participants who attended the 
2007–2009 screening clinic but were excluded from the final sample 
(Supplementary Table S1). 
The baseline characteristics of men and women are presented in  
Table 1. The proportions of non-whites, never smokers, non-drinkers, 
and of a lower grade of employment were higher in women than men. 
Women were more likely to have higher levels of depression (measured 
by the CES-D), cholesterol, and bedtime cortisol compared with men. On 
the other hand, the levels of SBP and MAP were lower in women than in 
men. The cortisol values decreased by approximately 12% each hour 
throughout the day (i.e., slope in cortisol) in both men and women 
(Fig. 2). 
The age-adjusted mean PWV changed from 8.486 m/s (standard 
error (SE) = 0.041) at baseline to 9.192 m/s (SE = 0.049) five years 
later for men and from 8.195 m/s (SE = 0.071) at baseline to 8.928 m/s 
(SE = 0.085) for women (Supplemental Fig. S3). 
The sex-specific multivariable-adjusted mean differences in PWV 
associated with a 1-SD difference in diurnal salivary cortisol at the 
baseline (2007–2009) are reported in Table 2. No associations between 
diurnal salivary cortisol and PWV were evident at baseline in either men 
or women. 
The sex-specific multivariable-adjusted mean difference in the five- 
year change in PWV associated with a 1-SD difference in diurnal sali-
vary cortisol is also presented in Table 2. A significant association be-
tween the five-year change in PWV and a 1-SD difference in salivary 
cortisol slope (β = 0.199; 95% confidence interval (CI) = 0.040, 0.358; 
Cohen’s D = 0.175) and bedtime cortisol (β = 0.208; 95% CI = 0.062, 
0.354; Cohen’s D = 0.191) was found in women. Women with flatter 
slopes of cortisol decline over the day and with higher bedtime cortisol 
levels at baseline showed larger increases in PWV (Fig. 3). However, no 
association of diurnal salivary cortisol with change in PWV over time 
was evident in men. 
5. Discussion 
Our longitudinal analysis found that the rate of increase in PWV as a 
measure of aortic stiffness over five years was associated with the 
baseline diurnal pattern of salivary cortisol in women. The greater in-
crease in PWV apparent among women who had flatter daytime cortisol 
and higher cortisol concentrations at bedtime remained after adjusting 
for an array of social, behavioral, and biologic factors, suggesting stress- 
related processes may be involved. We found no association of diurnal 
salivary cortisol with aortic stiffness in men. 
Disturbances in diurnal salivary cortisol have been related to a range 
of health outcomes apart from coronary heart disease, including dia-
betes (Hackett et al., 2016), cognitive decline (Gardner et al., 2019), and 
musculoskeletal strength (Gardner et al., 2013). The present study is the 
first to provide a direct test of the relationship between diurnal salivary 
cortisol and changes in PWV, using repeated measures over a period of 
years. Our findings were consistent with previous research that found an 
association between diurnal salivary cortisol and cardiovascular mor-
tality (Kumari et al., 2011). Ben-Shlomo et al. (2014) have reported that 
hazard ratio (95% CI) per SD change in loge-transformed PWV was 1.30 
(1.18, 1.43) and 1.28 (1.15, 1.43) for the risk of total cardiovascular 
disease events and cardiovascular mortality, respectively. Combining 
these results with previous studies may give some insight into the po-
tential functional significance of our findings in relation to the biological 
factors underlying the association between diurnal salivary cortisol and 
cardiovascular disease development or progression. 
Previous studies have reported mixed results in cross-sectional ana-
lyses of diurnal salivary cortisol and subclinical atherosclerosis out-
comes. One study found that a flattered diurnal salivary cortisol was 
associated with increased risk of coronary calcification (CCA) among 
participants with a mean age of 40 years old (Matthews et al., 2006), 
while Hajat et al. (2013) reported a null association between diurnal 
cortisol slope and CCA or ankle-brachial index among participants with 
a mean age of 65.6 years old. Similar to the findings from Hajat et al., we 
also did not find a cross-sectional relationship among participants with a 
mean age of 65.5 years old for men and 65.4 years old for women, but 
instead found a link between salivary cortisol and trajectories in PWV 
over time. Matthews et al. (2006) studied a relatively young sample, and 
it is possible that cortisol is more relevant to the early development of 
atherosclerosis rather than to people with existing subclinical disease. 
Thus, the effective impact of diurnal salivary cortisol, in the elderly, may 
not well reflect overall measures of PWV, but dynamic changes in PWV. 
Diurnal cortisol secretion is an important aspect of HPA-axis regu-
lation, in the adaptive responses to chronic stress. An increased cortisol 
level or a flatter diurnal slope in cortisol may be caused by impairment 
in the negative feedback of HPA axis activation and the regulation of 
circadian rhythm as indicative of higher chronic stress (Adam et al., 
2017). In the present study, we found that HPA-axis regulation is asso-
ciated with arterial stiffness in a sex-specific manner. Although the 
mechanism is not fully understood, sex hormones may be responsible for 
the sex differences in HPA-axis regulation and may contribute to the 
increased cortisol response to stress in women (Otte et al., 2005). We 
also found that bedtime cortisol was higher in women compared to men 
in the present older adult population. Women tend to be susceptible to 
chronic stress associated with traditional gender roles in home and 
workplace (O’Neil et al., 2018), which may have a profound impact on 
subclinical cardiovascular disease in women. Furthermore, women 
subjectively experience more stress than men, such that studies of 
Table 1 
Baseline characteristics (2007–2009) according to sex.   
Men (n = 2430) Women 
(n = 851)   
% or 
mean 
SD % or 
mean 
SD P for 
difference 
Age, year  65.5 5.70  65.4 5.77 0.70 
Non-white, %  5.32   11.5  <0.001 
Low social grade, %  3.21   22.3  <0.001 
CES-Da  4 1–8  6 2–11 <0.001 
Current smokers, %  4.95   3.65  0.12 
Alcohol drinkers (in the 
past week), %  
88.3   71.8  <0.001 
BMI, (kg/m2)  26.2 3.67  26.4 4.98 0.09 
Systolic blood pressure, 
mmHg  
125.6 14.9  121.9 16.6 <0.001 
Hypertension medication 
use, %  
30.6   30.0  0.72 
Arterial pressure, mmHg  90.8 10.4  87.8 11.0 <0.001 
Total cholesterol, mmol/l  5.12 1.00  5.58 1.07 <0.001 
Diabetes, %  2.22   2.70  0.43 
Slope in cortisol, nmol/lb  -0.12 0.02  -0.12 0.02 0.47 
Bedtime Cortisol, nmol/ 
lb  
0.61 0.83  0.69 0.84 0.02 
Pulse wave velocity, m/sc  8.66 2.18  8.44 2.22 0.01  
a Shows median and interquartile range and testing the significance per-
formed by Wilcoxon signed-rank test. 
b log-transformed. 
c earliest measure at either 2007–2009 or 2012–2013. 
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subjective emotion have found that women reported greater sadness and 
anxiety/fear than men (Fischer et al., 2004). Previous experimental 
studies have also suggested that there are sex differences in the re-
lationships between stress and behavioral arousal (Zellner et al., 2006) 
and some markers of cardiovascular risk (Girdler et al., 1990; Rannelli 
et al., 2017). Besides the sex differences in cortisol stress response, 
women experience a greater age-dependent increase in arterial stiffness, 
such that post-menopausal women’s large arteries are stiffer than 
similarly-aged men (Waddell et al., 2001). The age-adjusted mean PWV 
change in five years was also higher in women than in men in the present 
study. These sex differences in biological, social environment, and stress 
responses may influence the effect of diurnal salivary cortisol on the rate 
of change in PWV in the present study. 
The strengths of the study include the use of a well-characterized 
cohort of men and women who have been followed over a long period 
of time. A measure of PWV was obtained twice for most participants 
(70%). Nevertheless, there are some limitations to the present study. 
First, most of the associations described have small effect sizes, below 
0.2 as indicated by Cohen’s D measure of the standardised effect and 
confirmatory findings from other studies are necessary before these re-
sults can be generalised. Second, the men and women in this study were 
drawn from the same white-collar occupational cohort and therefore 
had similar work backgrounds. Thus, further research is needed to assess 
the possibility that associations between diurnal salivary cortisol and 
PWV may vary in more diverse populations. Third, we found some ev-
idence for a healthy survivor effect over the follow-up, which most likely 
led to underestimated effects of diurnal salivary cortisol on aortic stiff-
ness. This might explain why we found associations between diurnal 
salivary cortisol and longitudinal changes, but no cross-sectional dif-
ferences in aortic stiffness. Fourth, although cortisol was systematically 
sampled across the day, measures were taken on only one occasion, so 
we were not able to evaluate the consistency of assessments or long-term 
stability. Fifth, although we adjusted for various possible confounding 
factors in the current study, there is a possibility of residual confounding 
by unmeasured variables, such as inflammation (Nijm and Jonasson, 
2009) and genetic (Kudielka et al., 2009; van den Akker et al., 2008) 
influences that might account for cortisol response and cardiovascular 
disease. 
In summary, we found that, among women, flatter slopes of cortisol 
decline over the day and higher bedtime cortisol levels at baseline had 
greater increases in PWV. The association remained after adjusting for 
multiple biological and behavioral factors. Our findings also suggest that 
the pattern of association between the daytime slope and bedtime level 
of cortisol with cardiovascular health outcomes may be sex-specific. 
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supported by NordForsk, the Nordic Programme on the Health and 
Welfare, Academy of Finland, Finland (311492) and Helsinki Institute of 
Life Science, Finland. McEniery is supported by the National Institute for 
Health Research Cambridge Biomedical Research Centre, UK. Funding 
sources did not have a role in the design or conduct of the study; the 
collection, management, analysis, or interpretation of the data; or the 
preparation, review, approval, or decision to submit the manuscript. 
Declaration of Competing Interest 
The authors have nothing to disclose. 
Acknowledgments 
We thank all of the participating civil service departments and their 
welfare, personnel, and establishment officers; the British Occupational 
Health and Safety Agency; the British Council of Civil Service Unions; all 
participating civil servants in the Whitehall II study; and all members of 
the Whitehall II study team. The Whitehall II Study team comprises 
research scientists, statisticians, study coordinators, nurses, data man-
agers, administrative assistants, and data entry staff, who made this 
study possible. 
Appendix A. Supporting information 
Supplementary data associated with this article can be found in the 
online version at doi:10.1016/j.psyneuen.2021.105372. 
References 
Abell, J.G., Shipley, M.J., Ferrie, J.E., Kivimäki, M., Kumari, M., 2016. Recurrent short 
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